{"as_of":"2026-08-14T02:23:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:eb11cfa47a21d57a88aa07ea071f3e9ec3ba64cf740f9082915f77af6e6bb4e9","coverage":[{"denominator":58,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":58,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-12T20:21:13.435981Z","state":"measured"},{"denominator":58,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":58,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-13T06:32:02.005865+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2411.09820/citation-record","integrity":"/paper/2411.09820/integrity","json":"/paper/2411.09820/citation-record.json","paper":"/paper/2411.09820"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.901571Z","title":"https://www.meddra.org/","venue":null,"work_id":"f65a629c-59f5-4517-9ac4-72aaaa0f2135","year":2024},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.264251Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:6143dbd9fe1c1916e9aadd4a605232b24670a52c6306dcc101471ff6975e9a84","observation_id":"88628239-ad92-4111-8e99-43d195508550","resolution":{"observed_at":"2026-08-12T20:21:13.904186Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.893778Z","title":"Comprehensive behavioral analysis of male ox1r-/- mice showed implication of orexin receptor-1 in mood, anxiety, and social behavior","venue":null,"work_id":"adef47cf-5e24-4086-b14d-7d555f2a4c84","year":2015},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.268548Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:8aece9ac80167bb2939fd90cc895e9997fc036a5f4d8dac8ce70aa851121a150","observation_id":"b57aed11-017a-4f52-ae75-38ef384bf899","resolution":{"observed_at":"2026-08-12T20:21:13.896877Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.884853Z","title":null,"venue":null,"work_id":"62e01aba-cf49-4987-815d-7472de0e5e75","year":2007},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.271993Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:8cf42004add79a66616cc2dac45545c8808f3158cdc47f99e6e2ed68fc2add67","observation_id":"72aece50-039c-432f-8896-36a71f449f24","resolution":{"observed_at":"2026-08-12T20:21:13.888088Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.876713Z","title":"Muscarinic antagonist control of myopia: evidence for m4 and m1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew","venue":null,"work_id":"7647a488-b54e-430a-a6c5-b733e98ceeec","year":2012},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.276039Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:70440ceee134369dd649f71ee7a2b6fd8641c0353f32731ff9c2621c0f591b38","observation_id":"bb207ec9-0ef4-4539-9073-175673325edf","resolution":{"observed_at":"2026-08-12T20:21:13.879803Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.868898Z","title":"New substructure filters for removal of pan assay interference compounds (pains) from screening libraries and for their exclusion in bioassays","venue":null,"work_id":"2f1dee26-13f1-477e-a518-9128f8e8a4aa","year":2010},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.278741Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:728442bb2d0fdfc3f12c3314990d8e20d8488d532a588b93e89ce400f84fb055","observation_id":"9501e23e-56f6-4861-9b3b-c7de84d43d3b","resolution":{"observed_at":"2026-08-12T20:21:13.871547Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.860845Z","title":"The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of alzheimer disease","venue":null,"work_id":"9e62a3d0-3d1b-43f0-ab62-058a1c799f0c","year":1997},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.282283Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:79cfbf344776c5646e0aeacf994b2c9d68580a038f04a4d2369662fb438f4c4b","observation_id":"81860fde-dca5-4dac-bc00-f4ffbde889f7","resolution":{"observed_at":"2026-08-12T20:21:13.864515Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.853009Z","title":"Chemical modulation of kv7 potassium channels","venue":null,"work_id":"2bab2448-5481-47a4-a425-ede78755a9a0","year":2021},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.285190Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:78bc7766761f35766c7ded26c26fec23b8631395f89a25f27225723e8a70f6dc","observation_id":"bd36cd3a-e583-4cea-8594-166bd5dd9bca","resolution":{"observed_at":"2026-08-12T20:21:13.855795Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.843904Z","title":"The serine/threonine kinase stk33 exhibits autophosphorylation and phosphorylates the intermediate filament protein vimentin","venue":null,"work_id":"615d450c-73e0-4079-83b4-0d813036464a","year":2008},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.288130Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:aa9a5190e9f66a76987ffe545ad6f18ac9c7b6fab70e0c540271dd0454638076","observation_id":"9cea623c-69c9-4ff3-b107-60a52d5db9a3","resolution":{"observed_at":"2026-08-12T20:21:13.846764Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.836512Z","title":"Molecular structures: perception, autocorrelation descriptor and sar studies","venue":null,"work_id":"7fa78e21-9e3e-432c-8d81-32e695317145","year":1984},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.290734Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:36b0b5ba73fb74057916038f4149a856ca8a5a4d54944741e5ab8a4e31233d2e","observation_id":"b4378308-58eb-4521-b6b0-60e0cfb047fb","resolution":{"observed_at":"2026-08-12T20:21:13.839208Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.829344Z","title":"Muscarinic m1 receptor-stimulated adenylate cyclase activity in chinese hamster ovary cells is mediated by gs α and is not a consequence of phosphoinositidase c activation","venue":null,"work_id":"f3bf4d17-4900-4d51-b81f-af1a0f780ba4","year":1996},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.293346Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:25eac0e75ff72e7d2c3dceb5a219ecd19212dba58207b2b29a1a9553a7e6137f","observation_id":"bd810d77-d376-4c16-aa2c-2f2328e57b2a","resolution":{"observed_at":"2026-08-12T20:21:13.832328Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.822019Z","title":"High-throughput screening assay datasets from the pubchem database","venue":null,"work_id":"c22709f3-30fe-4297-a374-87df0bfc87de","year":2017},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.295926Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:08ddc04761d664b3995ed21cc8a2c05b36333b11195be7b3234682fc2890bb1b","observation_id":"b895fc6e-df39-4f7c-b9f3-641c4e166dd4","resolution":{"observed_at":"2026-08-12T20:21:13.825275Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.814206Z","title":"Targeting t-type/cav3","venue":null,"work_id":"3d9aba6b-2785-4a94-862f-e06a07e06cbc","year":2021},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.298516Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:c688978f316891403eaa49ca5e68fd3a783547c6bf836aa1d33aca7748ef1df5","observation_id":"0e51ee6c-c5d3-43aa-8207-d3cabfc01cc3","resolution":{"observed_at":"2026-08-12T20:21:13.816977Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.806931Z","title":"3d structure generator corina classic","venue":null,"work_id":"38f8c0cb-c25b-4fe3-89ed-1d33d7ee46cf","year":2019},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.301179Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:efb92e8cc9a231e7d6da6632df6fd5bd33bb37450fde715d59fedbb63cf59548","observation_id":"fa2ad748-edd7-4191-9beb-177e7ec03edf","resolution":{"observed_at":"2026-08-12T20:21:13.809934Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.798452Z","title":"Biopython: freely available python tools for computational molecular biology and bioinformatics","venue":null,"work_id":"5ad9c288-b23e-49c2-b117-1046eeffcfb4","year":2009},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.304068Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:0699b7c6dbaa99b9562a8e1a65a71682eb013dc6de86aaaa680cf2d0bb663d59","observation_id":"d67890b9-9c03-4159-afc8-69ce5939a451","resolution":{"observed_at":"2026-08-12T20:21:13.801361Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.790431Z","title":"Unique kir2","venue":null,"work_id":"1ca995e5-a7bc-4267-9188-c12a8a386c36","year":2004},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.307142Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:151cd7847cfc99daac41c4403c32e64deb028ade2022c779116fc211cac5f8c5","observation_id":"a1c81e6d-0c71-4224-a41e-80b027cad5af","resolution":{"observed_at":"2026-08-12T20:21:13.793544Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.782966Z","title":"Blockade of orexin-1 receptors atten- uates orexin-2 receptor antagonism-induced sleep promotion in the rat","venue":null,"work_id":"99b0d4ad-17d9-48fa-851c-b9bc1214b886","year":2009},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.309565Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:5273e090c77486f0738f69ad823892d85cb111dcd85d1298e12692a70f943049","observation_id":"e5707221-042d-418c-b863-add437319728","resolution":{"observed_at":"2026-08-12T20:21:13.785813Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.775255Z","title":"Pytorch geometric, 2019","venue":null,"work_id":"1bbbd8cf-f3d2-46b6-976c-780f54844c79","year":2019},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.312178Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:945a6872e1d0d76aad10c6167ca37c14809666f4ff365dd233478c138e849604","observation_id":"1a9006c9-186a-4e8f-a787-2193f46e0671","resolution":{"observed_at":"2026-08-12T20:21:13.778268Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2007.07029","last_updated":"2020-06-25T08:46:37Z","snapshot_observed_at":"2026-08-12T05:43:06.812401Z","submitted_at":"2020-06-25T08:46:37Z","title":"Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functions","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2007.07029","snapshot_observed_at":"2026-08-12T20:21:13.314798Z","title":"Deep learning for virtual screening: Five reasons to use roc cost functions","venue":null,"work_id":null,"year":2007},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.314798Z"},"links":{"cited_paper":"/paper/2007.07029","citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:f33c9f3c7fe7c547d7ffb7949f3601b6066ffcdaac0c75ee4b6f478d2d6018fc","observation_id":"df5d37ff-2d16-4ddd-9ea5-3673fa132020","resolution":{"observed_at":"2026-08-12T20:21:13.314798Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.766831Z","title":"International union of pharmacology","venue":null,"work_id":"4d961adc-09fb-47f1-b6d9-0a0cef724b20","year":2003},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.317629Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:364059d406c57d9057e524cba6f5444af9b136687ee5cc678c1794c868597624","observation_id":"0d8d9aea-3967-4cdd-96d1-8855541dee7b","resolution":{"observed_at":"2026-08-12T20:21:13.769429Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.758658Z","title":"Alzheimer’s disease: targeting the cholinergic system","venue":null,"work_id":"1bb8cfa9-36a6-4ab4-a0c0-bf93ef31ee23","year":2016},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.320934Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:03621649aa7b2d359d03e25b649524004ce0220a80129ae5c05cc1e0bd18ecdc","observation_id":"ad0cd3f1-e1f8-484e-9017-6539b6443b4f","resolution":{"observed_at":"2026-08-12T20:21:13.762209Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.749332Z","title":"Orexin a activates locus coeruleus cell firing and increases arousal in the rat","venue":null,"work_id":"732d6b8e-9abb-412f-891e-1b1416f19510","year":1999},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.324747Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:2545ac587a5f055256781d12f2752a1d6bc3b4d1b15e1cd48259859aa1de16c9","observation_id":"f861796d-d407-4387-925f-5f52f3902630","resolution":{"observed_at":"2026-08-12T20:21:13.753236Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.741390Z","title":"Glide: a new approach for rapid, accurate docking and scoring","venue":null,"work_id":"25517034-ac42-4b37-a976-7bfb8845501c","year":2004},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.327635Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:360c30fd65bd484c6afe178777c56588234b97c6098caa2e8eebe573f9c4e1ec","observation_id":"a7425d00-4760-4033-9925-51011f3515a7","resolution":{"observed_at":"2026-08-12T20:21:13.744053Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.732649Z","title":"Genetic variation of cacna1h in idiopathic generalized epilepsy.Annals of neurology, 55(4):595–596, 2004","venue":null,"work_id":"1dfffefc-ccd7-4966-a16d-5c6c6634c5f7","year":2004},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.330142Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:439b2b0d7ac5cc8081abaf7c051f0aac1738f7506f2bb013e76c60bc908747c5","observation_id":"43cdae86-c646-454d-b629-bb1ae925c1cc","resolution":{"observed_at":"2026-08-12T20:21:13.736090Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2102.09548","last_updated":"2021-08-28T19:59:03Z","snapshot_observed_at":"2026-08-13T20:12:29.004749Z","submitted_at":"2021-02-18T18:50:31Z","title":"Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2102.09548","snapshot_observed_at":"2026-08-12T20:21:13.332982Z","title":"Therapeutics data commons: Machine learning datasets and tasks for drug discovery and development","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.332982Z"},"links":{"cited_paper":"/paper/2102.09548","citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:692167a664f28811e569b97afefeaabebba9ee0a19f0cfedaf0d2d1a969ada8c","observation_id":"cbd2e1e3-b0c9-42b1-890e-7c16b2567633","resolution":{"observed_at":"2026-08-12T20:21:13.332982Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.724234Z","title":"Familial kcnq2 mutation: a psychiatric perspective","venue":null,"work_id":"1e41acf2-cf2b-4265-858d-cfd07bbc1ad9","year":2024},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.335958Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:428c010c1ef93eca6a448dd28ac1a33d6dafa1af07540089010eba2dc9bb9cc9","observation_id":"3c790bc8-58c5-4c1f-8568-60799983db76","resolution":{"observed_at":"2026-08-12T20:21:13.727360Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.716283Z","title":"Regulation of neuronal t-type calcium channels","venue":null,"work_id":"b436e78b-2eca-41bd-8805-c431bb0611e9","year":2009},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.339176Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:9c22ecaba5c774f8ece4e5fc19b353c1f857eb346cbc6b912d567ae762891a50","observation_id":"ae2bf637-4b83-4ba3-bf19-d356697e54b9","resolution":{"observed_at":"2026-08-12T20:21:13.718876Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.708475Z","title":"Ir evaluation methods for retrieving highly relevant documents","venue":null,"work_id":"15b567d5-e655-45c7-a905-c029b9d51f17","year":2017},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":27,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.342218Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:67a8e6012040d6a75533ec1041f8239b928aaf1c33e96b6cc6b17521dc170e7f","observation_id":"547cd562-071e-42b9-ab67-4d486348475c","resolution":{"observed_at":"2026-08-12T20:21:13.711513Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.700178Z","title":"Identification and characterization of the rat m1 muscarinic receptor promoter","venue":null,"work_id":"6c018981-4d13-4ad7-8a09-a4545532bcb0","year":1999},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":28,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.345525Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:702dd42237f3fde3681b9d9ebc977b29a9f8ad898ee5d95aa273a5f13c9f008e","observation_id":"dc168ed9-eba6-4167-89c0-3ef2946f6736","resolution":{"observed_at":"2026-08-12T20:21:13.703745Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.690755Z","title":"The sider database of drugs and side effects","venue":null,"work_id":"88066d67-d6fd-4120-b3ec-4c3101367beb","year":2016},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":29,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.349113Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:34f6cb5f5d7ae5f767b7f8b79f530a0517c9bb812d37c80220f6550d186eac05","observation_id":"5bee1719-06f5-4300-b00e-b2a0c4632110","resolution":{"observed_at":"2026-08-12T20:21:13.693663Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.351877Z","title":"Rdkit documentation","venue":null,"work_id":null,"year":2013},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":30,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.351877Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:ffc4788eb63386f86a9f480b1ffb265b06cb9a95c074b8d341f6b7e0848e7e6e","observation_id":"8bf8f6e2-0799-4913-9c83-1877535bc48c","resolution":{"observed_at":"2026-08-12T20:21:13.351877Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.678781Z","title":"The embl-ebi bioinformatics web and programmatic tools framework","venue":null,"work_id":"456a5705-05c3-41c5-9bd6-ab3f1fb1fe88","year":2015},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":31,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.354998Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:b2faf686c624a7fb391a5cbee7fc4dda19b2312b29578fd480a227d6b9ced6e6","observation_id":"e3bb7991-b443-4ef6-a57c-495c56ad0bb4","resolution":{"observed_at":"2026-08-12T20:21:13.681481Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.670414Z","title":"Inhibition of human tyrosyl-dna phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors","venue":null,"work_id":"a60758fa-95e5-443c-becb-afc4f1dc173c","year":2006},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":32,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.357590Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:89d893402336a56f0276a5f75cbb0445b5f25f5265792471f4252a42732c4b90","observation_id":"a155724d-0f21-4407-85ca-f594d8f2c612","resolution":{"observed_at":"2026-08-12T20:21:13.673102Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2102.05013","last_updated":"2022-11-24T22:41:20Z","snapshot_observed_at":"2026-08-03T15:39:41.620279Z","submitted_at":"2021-02-09T18:31:23Z","title":"Spherical Message Passing for 3D Graph Networks","version":5},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2102.05013","snapshot_observed_at":"2026-08-12T20:21:13.361209Z","title":"Spherical message passing for 3d graph networks","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":33,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.361209Z"},"links":{"cited_paper":"/paper/2102.05013","citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:8c8f0b5c77c6f18b7cf6fe687d25d2f7c54cab282af871ccbefebfb668b7a671","observation_id":"572f288f-81ad-48c8-8733-573c6a7088d4","resolution":{"observed_at":"2026-08-12T20:21:13.361209Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.662136Z","title":"Interpretable chirality-aware graph neural network for quantitative structure activity relationship modeling in drug discovery","venue":null,"work_id":"1300f79c-4ed2-45af-bf73-e3a6caa49f0f","year":2023},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":34,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.364551Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:6f404b01a31735221c5ed81cab3adec6779a2b3733a38b0fcc312c649ce2da18","observation_id":"8fb29ae8-66f7-4c59-a850-ddf7890fdf74","resolution":{"observed_at":"2026-08-12T20:21:13.665685Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.655122Z","title":"Effects of central muscarinic-1 receptor stimulation on blood pressure regulation","venue":null,"work_id":"da836b5c-93ea-419c-82f2-b3c9ffb74505","year":1997},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":35,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.368927Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:8d2f0c65bb269832d1e2785a93c64f4ecc7b478774829a3707fab9b42282a13e","observation_id":"90fa9d69-ad0d-46a5-b001-e358db79e398","resolution":{"observed_at":"2026-08-12T20:21:13.657961Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.648112Z","title":null,"venue":null,"work_id":"db674401-1593-4da1-ad2e-84b0c252da52","year":2012},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":36,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.371446Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:a3b4e72c21dff28ca9c8452676dd49566f867fef8807560a20c128b3015d1774","observation_id":"9f61a854-fdd5-47a2-82d1-2bc92f43632b","resolution":{"observed_at":"2026-08-12T20:21:13.650738Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.639959Z","title":"The autocorrelation of a topological structure: A new molecular descriptor","venue":null,"work_id":"52720eb9-ac05-4497-a2c9-a287213505bd","year":1980},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":37,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.374722Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:ef8dc73669a721c2177eb8ddf2834dc8efb8c76b0d3cc81ab7638b916086668f","observation_id":"d1910dc2-fb6b-472a-86bb-727eb3475e8f","resolution":{"observed_at":"2026-08-12T20:21:13.643096Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.631500Z","title":"Rapid context-dependent ligand desolvation in molecular docking","venue":null,"work_id":"1a73e94a-363e-40db-a492-1cabe867fddd","year":2010},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":38,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.378301Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:81df43c012e36175d9269b2f223a181e25a8c2b3a0322e0e2b2e0648c53b0ec0","observation_id":"62beba71-6b33-45c0-88c3-a134e680ef7e","resolution":{"observed_at":"2026-08-12T20:21:13.635516Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.622418Z","title":"The role of t-type calcium channels in epilepsy and pain","venue":null,"work_id":"36b7e8e8-9905-42a2-bc39-ab82db4012c4","year":2006},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":39,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.380950Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:8d696dee07b7bafc5e76b4f8f61a5262ae4b777dad6a1bc9dab3c080738daa35","observation_id":"14508762-861e-43a9-ab72-491edb1c7cac","resolution":{"observed_at":"2026-08-12T20:21:13.626645Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.614212Z","title":"High-affinity choline transporter","venue":null,"work_id":"8227f293-e8b0-4d3b-8d2a-1d1b83ab4b14","year":2003},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":40,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.383557Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:e38fe6c19c16198e2a87af70103e1baed3cee9fdaa55524cac85b58c69551304","observation_id":"b78e931c-fc32-4b76-ada8-71853be9c3ac","resolution":{"observed_at":"2026-08-12T20:21:13.617071Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.606071Z","title":"Improved scoring of ligand- protein interactions using owfeg free energy grids","venue":null,"work_id":"df36ba0c-90fd-499a-ac0f-88f5311aaf0d","year":2001},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":41,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.386326Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:d0830bad463f5a072a22a73ca998efb5196480e6348193f9985f0ea27b0f3042","observation_id":"5e7b330e-6545-4f70-b236-166fcfd04ddc","resolution":{"observed_at":"2026-08-12T20:21:13.609078Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.597861Z","title":"Molecular physiology of low-voltage-activated t-type calcium channels","venue":null,"work_id":"cb6ebbe2-91f6-498c-b709-2b5c882d83f0","year":2003},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":42,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.388928Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:c389cdfe99f8be88090b51842ceed2e49983a8f7d158f80708cb43f8372594b4","observation_id":"3583cf45-7c85-46fc-b988-ba9075565c9b","resolution":{"observed_at":"2026-08-12T20:21:13.600691Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.590250Z","title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","venue":null,"work_id":"e4a380b6-cc56-4ed2-bb05-88b776f7bbb9","year":2012},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":43,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.391920Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:6f3f6b5a31d6f8263c81fb1816e3cc8098481355af39fd81d0554e9e14ac92f7","observation_id":"6192c68c-9452-441e-bf17-7f5ef5f07e7d","resolution":{"observed_at":"2026-08-12T20:21:13.593090Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"1502.02072","last_updated":"2015-02-06T23:04:01Z","snapshot_observed_at":"2026-08-01T18:48:32.102204Z","submitted_at":"2015-02-06T23:04:01Z","title":"Massively Multitask Networks for Drug Discovery","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"1502.02072","snapshot_observed_at":"2026-08-12T20:21:13.395218Z","title":"Massively multitask networks for drug discovery","venue":null,"work_id":null,"year":2015},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":44,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.395218Z"},"links":{"cited_paper":"/paper/1502.02072","citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:6a6afe11138c44227b944f7c11239320ac8db268bae4ba0b3acd96799146d126","observation_id":"a2b6de0f-d567-4b5c-b321-0a53e1218661","resolution":{"observed_at":"2026-08-12T20:21:13.395218Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.582166Z","title":"Maximum unbiased validation (muv) data sets for virtual screening based on pubchem bioactivity data","venue":null,"work_id":"9754045e-2c78-4c83-a293-58acc50c6f34","year":2009},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":45,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.398270Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:4a3c8ae96b62018ebc7e13506197770eb4879d4daa96a7bbe65d96ceb761458d","observation_id":"4e727d8f-433e-4068-a5e4-c43ed3ad568f","resolution":{"observed_at":"2026-08-12T20:21:13.585116Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.574498Z","title":"Synthetic lethal interaction between oncogenic kras dependency and stk33 suppression in human cancer cells","venue":null,"work_id":"7f1194e3-08d5-43e4-9636-fcadfd37efa2","year":2009},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":46,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.401222Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:b3d9c7148f01be19ee205efd87e0a042b0bbb530420743871307009a97e50f53","observation_id":"324741c6-1e70-4048-a757-8382d5c2c624","resolution":{"observed_at":"2026-08-12T20:21:13.577629Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.404850Z","title":"Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":47,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.404850Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:599f62b844fe7ec05c0ca53517f4e0d7ae78c00cb43d213f5af55ea463ba7b13","observation_id":"12481cf6-d17c-45d3-ad14-e81299e062e8","resolution":{"observed_at":"2026-08-12T20:21:13.404850Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.560899Z","title":"Fluorescence spectroscopic profiling of compound libraries","venue":null,"work_id":"884f817f-9bf9-4496-bea8-4ef186970d83","year":2008},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":48,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.407489Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:09abce3ec5bdb02027229f6c3691cb980bc7f5c562f5b33ef195d613a1928d80","observation_id":"ee888f01-73b0-4e16-854f-c6ed166cfc0f","resolution":{"observed_at":"2026-08-12T20:21:13.564571Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.553374Z","title":"Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking","venue":null,"work_id":"525c6f09-8f63-432c-bb32-1f7e24bc00d3","year":2009},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":49,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.410250Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:eed327b6ebe3d3410da28623f61d6f8efd696bf70cb7ea0e87fc70f0c1c11dbc","observation_id":"aa476004-33f2-418f-889f-4643dd1b16ff","resolution":{"observed_at":"2026-08-12T20:21:13.556610Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.545078Z","title":"Chronic inhibition of cardiac kir2","venue":null,"work_id":"c14e47bc-397b-4c28-b22f-8cef4590dcb7","year":2006},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":50,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.412998Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:42c3b1a5ba8e9f846f7dd7a46bf6f5439aab6abd3b0ca398986ec8303adc70bc","observation_id":"872d5943-8fc9-40eb-95f1-30d58dbadc9c","resolution":{"observed_at":"2026-08-12T20:21:13.548035Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.536043Z","title":"We Need Better Benchmarks for Machine Learning in Drug Discovery","venue":null,"work_id":"77ab3419-271d-4062-8df8-f27c8aa8db42","year":2023},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":51,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.415784Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:33be2237801d1ec1e6321b88bac38df951b5739f0292248b56349605872dd47f","observation_id":"a436a7cf-6959-415c-8860-cefc8f89052a","resolution":{"observed_at":"2026-08-12T20:21:13.539404Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.528456Z","title":"Deep graph library (dgl), 2019","venue":null,"work_id":"2c696356-a73c-404d-adc0-6c7a7dfadf62","year":2019},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":52,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.418638Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:3612636d681d1b0f7bbf293aa86f18747dcfc07630e643ef432014306a7ada9b","observation_id":"78a111ae-268d-4d98-98c0-50e633b58322","resolution":{"observed_at":"2026-08-12T20:21:13.531369Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.519706Z","title":"Database resources of the national center for biotechnology information","venue":null,"work_id":"21a09954-2607-4972-b2b4-ffbd429c0891","year":2007},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":53,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.421560Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:74465a274adf6616a896193a5ba278207a628273e9e238f317e8cfeee9866e87","observation_id":"e09516af-f5cc-490c-8503-e25b0382c496","resolution":{"observed_at":"2026-08-12T20:21:13.522967Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.511623Z","title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","venue":null,"work_id":"53a89037-178c-4bc6-abf8-f7c4c0ac9b0d","year":1981},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":54,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.424807Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:3d99eec5fc8cbf963d67de0b29c3e7b4369fa4c81fb00b8e6ce86a70fd09efab","observation_id":"8dfaf09b-f5cf-42ec-845d-03e6027b255e","resolution":{"observed_at":"2026-08-12T20:21:13.514564Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.502487Z","title":"Differential effects of m1 and m2 receptor antagonists in perirhinal cortex on visual recognition memory in monkeys","venue":null,"work_id":"f35651d8-2eac-4c87-aa2e-4119982feb93","year":2012},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":55,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.427303Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:2c4bf9c66b07b32f64a032ed34cc87da55b73c186c138367bd41bc26bc5201b9","observation_id":"f3aa91e4-2920-4de7-a709-d74fd13cfe4d","resolution":{"observed_at":"2026-08-12T20:21:13.505816Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.429876Z","title":"Moleculenet: a benchmark for molecular machine learning","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":56,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.429876Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:8f4c9d7e251d1b968bd5cf73e7ee3e29d56f9b222ace86117c43ea9a6a45387c","observation_id":"74e5bc53-d5f8-4c19-b1da-68a268f02908","resolution":{"observed_at":"2026-08-12T20:21:13.429876Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.489562Z","title":"Frequent hitters: nuisance artifacts in high-throughput screening","venue":null,"work_id":"6f04386c-b82c-4281-a1cb-8fd4731f5a58","year":2020},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":57,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.432647Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:2e3aac6c86e1dbb1bddf3f5db3a3dff2d18d49a8c4bdf8d558afbd5d589402aa","observation_id":"38cb3bf5-4e5b-420b-9b5c-67fd10df0ba8","resolution":{"observed_at":"2026-08-12T20:21:13.492924Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T20:21:13.479105Z","title":"Novel neuroprotective k+ channel inhibitor identified by high-throughput screening in yeast","venue":null,"work_id":"543cdc05-3183-41ed-acf1-1a3a02e81684","year":2004},"citing_paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking","version":1},"reference_index":58,"source":"pdf_text","source_observed_at":"2026-08-12T20:21:13.435981Z"},"links":{"citing_paper":"/paper/2411.09820"},"observation_digest":"sha256:be4766cff780a10fce31871c83967297b49a7ad77f13c55ef8067abe868a6c2d","observation_id":"3edc9a71-2a17-4ced-a27d-04bece044d0e","resolution":{"observed_at":"2026-08-12T20:21:13.483483Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-13T06:32:02.005865+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"state":"measured"}}],"paper":{"arxiv_id":"2411.09820","last_updated":"2024-11-14T21:49:41Z","latest_version":1,"primary_category":"cs.LG","snapshot_observed_at":"2026-08-12T20:14:50.713862Z","submitted_at":"2024-11-14T21:49:41Z","title":"WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking"},"reference_resolution":{"displayed":58,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":9,"verified_exact":0,"verified_fuzzy":49},"total_outbound_references":58},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-13T06:32:02.005865+00:00","source":"crossref"},{"observed_at":"2026-08-13T06:31:53.387327+00:00","source":"retraction_watch"}],"thesis":"As of 14 August 2026, this Paper Citation Record lists 58 of 58 outbound references and 0 inbound Pith citation observations for arXiv:2411.09820."}